Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KN3835 vs Placebo in Flexible/Semi-Flexible Hammertoe
NCT07759362Phase 3Recruiting
- Sponsor
- Keenova Therapeutics
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in hammertoe, sponsored by Keenova Therapeutics. Started Aug 2026; status: recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
hammertoe
Beyond the preview
Go deeper on NCT07759362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759362.